These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26328154)

  • 21. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
    Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-Risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?
    Tadrist A; Gondran-Tellier B; McManus R; Al Balushi K; Akiki A; Gaillet S; Delaporte V; Karsenty G; Lechevallier E; Boissier R; Baboudjian M
    J Endourol; 2021 Jul; 35(7):1042-1046. PubMed ID: 33626963
    [No Abstract]   [Full Text] [Related]  

  • 23. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
    Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Escrig JLD; Hernández V; Peyronnet B; Seisen T; Soukup V
    Eur Urol; 2019 Nov; 76(5):639-657. PubMed ID: 31443960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
    Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current European Trends in Endoscopic Imaging and Transurethral Resection of Bladder Tumors.
    Waldbillig F; Hein S; Grüne B; Suarez-Ibarrola R; Liatsikos E; Salomon G; Reiterer A; Gratzke C; Miernik A; Kriegmair MC; Ritter M
    J Endourol; 2020 Mar; 34(3):312-321. PubMed ID: 31617417
    [No Abstract]   [Full Text] [Related]  

  • 26. Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
    Kobayashi K; Matsuyama H; Kawai T; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Komura K; Abe T; Kume H; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Inoue K; Mitsui T; Kawakita M; Ohyama C; Mizokami A; Kuroiwa H
    Int J Urol; 2022 Jul; 29(7):632-638. PubMed ID: 35293022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Narrow band imaging-assisted holmium laser resection reduced the recurrence rate of non-muscle invasive bladder cancer: a prospective, randomized controlled study].
    Ma T; Wang W; Jiang Z; Shao G; Guo L; Li J; Zhang L; Liu Y
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(37):3032-5. PubMed ID: 26814085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the efficacy and feasibility of laser enucleation of bladder tumor versus transurethral resection of bladder tumor: a meta-analysis.
    Yang H; Wang N; Han S; Male M; Zhao C; Yao D; Chen Z
    Lasers Med Sci; 2017 Dec; 32(9):2005-2012. PubMed ID: 28831631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Pak JS; Haas CR; Anderson CB; DeCastro GJ; Benson MC; McKiernan JM
    Urol Oncol; 2021 Nov; 39(11):787.e9-787.e15. PubMed ID: 33865688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New optical imaging technologies for bladder cancer: considerations and perspectives.
    Liu JJ; Droller MJ; Liao JC
    J Urol; 2012 Aug; 188(2):361-8. PubMed ID: 22698620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated transurethral resection for non-muscle invasive bladder cancer.
    Cao M; Yang G; Pan J; Sun J; Chen Q; Chen Y; Chen H; Xue W
    Int J Clin Exp Med; 2015; 8(1):1416-9. PubMed ID: 25785148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study.
    Zhang Y; Xie L; Chen T; Xie W; Wu Z; Xu H; Xing C; Sha N; Shen Z; Qie Y; Liu X; Hu H; Wu C
    Onco Targets Ther; 2016; 9():605-11. PubMed ID: 26869805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.
    Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z
    Oncology; 2024; 102(4):337-342. PubMed ID: 37647883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality Control Indicators for Transurethral Resection of Non-Muscle-Invasive Bladder Cancer.
    Akand M; Muilwijk T; Raskin Y; De Vrieze M; Joniau S; Van Der Aa F
    Clin Genitourin Cancer; 2019 Aug; 17(4):e784-e792. PubMed ID: 31097388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive bladder cancer: basic skills.
    Furuse H; Ozono S
    Int J Urol; 2010 Aug; 17(8):698-9. PubMed ID: 20649827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer.
    Xishuang S; Deyong Y; Xiangyu C; Tao J; Quanlin L; Hongwei G; Jibin Y; Dongjun W; Zhongzhou H; Jianbo W; Lina W; Lin Y
    J Endourol; 2010 Jan; 24(1):69-73. PubMed ID: 19954353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer.
    Atta MA; Kotb AF; Sharafeldeen M; Elabbady A; Hashad MM
    Arab J Urol; 2017 Mar; 15(1):60-63. PubMed ID: 28275520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.